The Next ‘Cybersecurity Moment’ is Health-Tech

Why This Is the Best Time in a Decade to Invest in Category-Defining Health-Tech Companies

Fifteen years ago, cybersecurity was considered a niche infrastructure market. Most

enterprises viewed security as a cost center, budgets were limited, and only a handful of investors specialized in the space. Today, cybersecurity has become one of the largest and most valuable technology sectors in the world, producing dozens of unicorns, multiple IPOs, and acquisitions worth tens of billions of dollars.

Health-tech today is remarkably similar to where cybersecurity stood a decade ago.

The companies that will define healthcare over the next twenty years are being built today. For investors willing to look beyond current market sentiment, this may represent one of the most attractive venture investment opportunities of the coming decade.

Looking Back: The Cybersecurity Investment Thesis

The cybersecurity boom was not driven by a single breakthrough technology. Instead, several structural forces converged simultaneously:

Digital transformation dramatically expanded the attack surface.
Cloud computing fundamentally changed enterprise architecture.
Governments introduced increasingly stringent regulations.
Cyberattacks became more frequent, sophisticated, and expensive.
Security spending shifted from optional insurance to mission-critical infrastructure.

Importantly, investors who recognized these structural shifts before the market reached consensus generated extraordinary returns.

Companies such as Palo Alto Networks, CrowdStrike, Wiz, CyberArc, SentinelOne, Okta, Zscaler, and many others became category leaders not because they solved incremental problems, but because they redefined entirely new markets.

Healthcare is now entering a similar phase of structural transformation.

Healthcare Is Reaching Its Inflection Point

For decades, healthcare has lagged behind almost every other industry in digital adoption.

Clinical workflows remain fragmented. Data continues to reside in disconnected silos. Administrative costs consume an enormous share of healthcare spending. Decision-making often relies on incomplete information. Workforce shortages continue to worsen globally.

These challenges are no longer sustainable.

Unlike previous technology cycles, healthcare is now experiencing simultaneous transformation across regulation, reimbursement, artificial intelligence, data infrastructure, diagnostics, therapeutics, and patient engagement.

History shows that when multiple structural trends converge simultaneously, entirely new technology leaders emerge.

AI Has Changed the Economics of Healthcare Innovation

The emergence of foundation models and generative AI has fundamentally altered what healthcare software can accomplish.

For the first time, software can:

interpret complex clinical documentation,
assist physicians in diagnosis,
automate administrative workflows,
identify disease patterns across multimodal datasets,
personalize treatment recommendations,
accelerate clinical research,
improve operational efficiency across health systems.

Healthcare has always been data rich but insight poor. Artificial intelligence is finally bridging that gap.

Importantly, AI is not simply making existing software more efficient - it is enabling entirely new categories of products that previously could not exist.

Healthcare Is Becoming an Infrastructure Market

Cybersecurity eventually became infrastructure. Organizations cannot operate without identity management, endpoint protection, threat detection, and cloud security. Healthcare is following the same trajectory.

Several technology layers are becoming foundational infrastructure:

AI clinical copilots
Precision diagnostics
Digital pathology
Genomic analytics
Remote patient monitoring
Hospital workflow automation
Population health intelligence
Clinical decision support
Revenue cycle automation
Digital therapeutics

Each of these categories has the potential to produce multiple billion-dollar companies. Many remain surprisingly early.

The Demand Drivers Are Structural, Not Cyclical

Perhaps the strongest investment argument is that healthcare innovation is being driven by forces that are largely independent of economic cycles. Global healthcare systems face:

ageing populations,
rising chronic disease prevalence,
severe clinician shortages,
increasing healthcare expenditures,
growing patient expectations,
mounting regulatory pressure.

These trends are unlikely to reverse. Technology is no longer viewed as optional - it has become essential for healthcare systems to remain financially and operationally sustainable. This creates unusually resilient long-term demand.

Regulation Is Becoming a Tailwind

Historically, investors viewed healthcare regulation as a barrier. Increasingly, it is becoming an accelerator.

Governments and regulators worldwide are promoting:

interoperability,
electronic health records,
digital diagnostics,
AI governance,
remote care,
value-based reimbursement,
real-world evidence.

These frameworks reduce adoption risk while expanding addressable markets. Just as cybersecurity benefited from stricter compliance requirements, health-tech increasingly benefits from policy support rather than policy resistance.

Data Is Finally Becoming Actionable

Healthcare generates enormous quantities of information. Until recently, most of this data remained inaccessible or unusable. Today, advances in cloud infrastructure, interoperability standards, imaging technologies, genomics, wearable devices, and AI are making healthcare data actionable at scale.

The competitive advantage increasingly belongs to companies capable of transforming fragmented clinical data into actionable intelligence. This mirrors how cybersecurity companies transformed billions of security events into real-time threat detection.

The Window Is Open - but It Will Not Stay Open Forever

Every major technology cycle follows a familiar pattern. First comes skepticism. Then early adoption. Then rapid enterprise deployment. Finally, widespread market consensus. The greatest venture returns are typically generated before consensus emerges.

Healthcare appears to be entering precisely this phase today. Valuations have normalized following the correction in digital health markets. Capital has become more disciplined. Founders are building companies with stronger fundamentals.

Meanwhile, AI capabilities continue to improve at an unprecedented pace. Historically, these conditions have created exceptional venture investment environments.

What Will Define the Next Category Leaders?

The next generation of health-tech leaders is unlikely to succeed by simply digitizing existing workflows. Instead, they will fundamentally reshape how healthcare is delivered.

The defining characteristics of future category leaders are likely to include:

AI-native products rather than AI-enabled features.
Deep integration into clinical workflows.
Demonstrable improvements in clinical outcomes.
Clear economic value for providers and payers.
Strong regulatory and reimbursement strategies.
Proprietary datasets that create durable competitive advantages.
Scalable global business models.

Technology alone will not be sufficient. Execution, trust, clinical validation, and distribution will increasingly separate winners from followers.

Lessons from Cybersecurity

The biggest lesson from cybersecurity is not that one should invest in every company operating within a rapidly growing sector. Rather, it is that periods of structural transformation create entirely new categories. The most valuable companies are often those that define those categories before the market recognizes they exist.

Healthcare is approaching such a moment. The combination of artificial intelligence, demographic pressures, regulatory evolution, digital infrastructure, and unprecedented demand for healthcare efficiency is creating the conditions for a new generation of global market leaders.

Conclusion

Every decade produces one or two technology sectors that redefine venture investing.

Cloud computing did. Mobile did. Cybersecurity did. Artificial intelligence is doing so today.

Healthcare sits at the intersection of all these transformations.

For investors, the opportunity is not simply to fund better healthcare software. It is to back the companies that will become the foundational infrastructure of modern healthcare.

Just as cybersecurity produced the defining enterprise technology companies of the last decade, health-tech has the potential to produce the defining technology companies of the next one.

The next category leaders are already being built.

The question is no longer whether healthcare will transform - it is who will lead that transformation.

---

Uri Adoni is one of four Partners at Havilland Active Ventures, which invests in UK, US, European and Middle Eastern healthtech from seed to Series B.

This article is provided for general information only. It does not constitute investment advice, nor an offer or solicitation to invest in any fund or security. References to third-party companies are drawn from public reporting and do not imply any relationship with Havilland Active Ventures.